Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial

BACKGROUND: Estrogen is involved in the pathogenesis of breast and gynecological cancers. Regular use of aspirin reduces estrogen levels. The present study aimed to evaluate the effect of aspirin on estrogen levels in postmenopausal women. METHODS: This double-blind, placebo-controlled parallel-grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Oghazian, Mohammad Bagher, Shirzad, Nooshin, Ahadi, Mahdi, Eivazi Adli, Shalaleh, Mollazadeh, Samaneh, Radfar, Mania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116012/
https://www.ncbi.nlm.nih.gov/pubmed/35581629
http://dx.doi.org/10.1186/s40360-022-00571-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116012/
https://www.ncbi.nlm.nih.gov/pubmed/35581629
http://dx.doi.org/10.1186/s40360-022-00571-9

Ejemplares similares